Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorWright State University

About this trial

This study is following up on previous studies that have demonstrated that geriatric subjects respond different to ultraviolet B (UVB) light than young subjects. The treatment of geriatric skin with dermal rejuvenation therapies (dermabrasion, fractionated laser resurfacing) restores the appropriate UVB response. Ongoing studies have tested the ability of fractionated laser resurfacing (FLR) to assess how long this wounding effect lasts-and have found that this appears to be a durable response which lasts for at least two years. The findings that FLR protects geriatric skin at two years is the impetus for this study.

This study is an interventional study to assess if FLR treatment of one forearm of geriatric subjects with multiple actinic keratosis will result in the short-term removal of actinic keratosis, and the long-term decrease in levels of future actinic keratosis and other non-melanoma skin cancers in comparison to the untreated arm.

Study length and visit: The first part of the study is completed in 1 day then there are follow up visits at 90 days and every 6 months for 5 years.

Eligibility criteria

Qualifiers

Diagnosed with Actinic Keratosis within the past 6 months

At least 60 years of age, or older

Ability to comprehend procedures and risks versus benefits

Able to provide Informed Consent

Disqualifiers

Uncontrolled Diabetes Mellitus

Not able to comprehend procedures or risks versus benefits

Pregnant or nursing

Large tattoos on forearms

Trial design

Treatments tested in this trial

  • Fractionated Laser Resurfacing

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators